ALBERT DAVID
Quarterly Results Analysis [Dec2023]
ALBERT DAVID Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹88 Cr | ₹93 Cr | ₹92 Cr | ₹81 Cr | ₹75 Cr | ₹92 Cr | ₹93 Cr | ₹74 Cr |
Expenses | ₹80 Cr | ₹77 Cr | ₹79 Cr | ₹72 Cr | ₹66 Cr | ₹78 Cr | ₹81 Cr | ₹64 Cr |
Operating Income | ₹8 Cr | ₹16 Cr | ₹13 Cr | ₹10 Cr | ₹8 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr |
Other Income | ₹17 Cr | ₹12 Cr | ₹18 Cr | ₹0 Cr | ₹7 Cr | ₹14 Cr | ₹-6 Cr | ₹-1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹23 Cr | ₹27 Cr | ₹29 Cr | ₹7 Cr | ₹14 Cr | ₹26 Cr | ₹4 Cr | ₹7 Cr |
Profit After Tax | ₹19 Cr | ₹20 Cr | ₹23 Cr | ₹4 Cr | ₹11 Cr | ₹20 Cr | ₹2 Cr | ₹4 Cr |
EPS | ₹32.80 | ₹35.57 | ₹41.16 | ₹6.54 | ₹18.48 | ₹35.28 | ₹3.08 | ₹7.32 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALBERT DAVID | 0.3% | -21.1% | 106.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ALBERT DAVID Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -5.25 % |
Y-o-Y | 18.39 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹88 Cr | -5.25 | |
Sep2023 | ₹93 Cr | 1.34 | |
Jun2023 | ₹92 Cr | 12.93 | |
Mar2023 | ₹81 Cr | 9.19 | |
Dec2022 | ₹75 Cr | -19.28 | |
Sep2022 | ₹92 Cr | -0.88 | |
Jun2022 | ₹93 Cr | 25.31 | |
Mar2022 | ₹74 Cr | - |
ALBERT DAVID Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -47.67 % |
Y-o-Y | 0.82 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹8 Cr | -47.67 | |
Sep2023 | ₹16 Cr | 22.89 | |
Jun2023 | ₹13 Cr | 35.41 | |
Mar2023 | ₹10 Cr | 15.79 | |
Dec2022 | ₹8 Cr | -41.84 | |
Sep2022 | ₹14 Cr | 16.60 | |
Jun2022 | ₹12 Cr | 22.02 | |
Mar2022 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -44.78 % |
Y-o-Y | -14.85 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 9.46% | -44.78 | |
Sep2023 | 17.13% | 21.23 | |
Jun2023 | 14.13% | 19.95 | |
Mar2023 | 11.78% | 6.03 | |
Dec2022 | 11.11% | -27.95 | |
Sep2022 | 15.42% | 17.62 | |
Jun2022 | 13.11% | -2.60 | |
Mar2022 | 13.46% | - |
ALBERT DAVID Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -7.78 % |
Y-o-Y | 77.46 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹19 Cr | -7.78 | |
Sep2023 | ₹20 Cr | -13.59 | |
Jun2023 | ₹23 Cr | 528.94 | |
Mar2023 | ₹4 Cr | -64.59 | |
Dec2022 | ₹11 Cr | -47.62 | |
Sep2022 | ₹20 Cr | 1,046.75 | |
Jun2022 | ₹2 Cr | -57.94 | |
Mar2022 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -2.66 % |
Y-o-Y | 49.82 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 21.2 % | -2.66 | |
Sep2023 | 21.78 % | -14.76 | |
Jun2023 | 25.55 % | 456.64 | |
Mar2023 | 4.59 % | -67.56 | |
Dec2022 | 14.15 % | -35.09 | |
Sep2022 | 21.8 % | 1,059.57 | |
Jun2022 | 1.88 % | -66.49 | |
Mar2022 | 5.61 % | - |
ALBERT DAVID Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -7.79 % |
Y-o-Y | 77.49 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹32.8 | -7.79 | |
Sep2023 | ₹35.57 | -13.58 | |
Jun2023 | ₹41.16 | 529.36 | |
Mar2023 | ₹6.54 | -64.61 | |
Dec2022 | ₹18.48 | -47.62 | |
Sep2022 | ₹35.28 | 1,045.45 | |
Jun2022 | ₹3.08 | -57.92 | |
Mar2022 | ₹7.32 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD